BioBiz Buzz
BioBiz Buzz offers exclusive insights into the biotech, pharma, and medtech industries through interviews with top executives and visionaries.
Providing thought-provoking podcasts covering topics such as scientific advancements, emerging technologies, and market trends, to keep listeners informed about the latest developments in life sciences.
Disclaimer
https://biobizbuzz.com/disclaimer/
BioBiz Buzz
Latest Episodes
28. Reawakening Wnt Biology: Neuvasq’s Approach to Restoring Retinal Vascular Integrity
In this episode of BioBiz Buzz, your host Mike Ward explores a critical, but often underappreciated, driver of vision loss in retinal diseases; the breakdown of the blood–retina barrier (BRB). While anti-VEGF therapies have transformed outcomes...
27. Microbiome Medicines at Scale: MRM Health’s Mission to Redefine Immune-Mediated Disease
In this episode of BioBiz Buzz, Mike Ward talks to Dr Sam Possemiers, founder and CEO of Belgium-based MRM Health, about what it really takes to turn the human gut microbiome into a bona fide drug modality. They trace the arc from crude faecal ...
26. Induced Proximity 2.0: How Proxygen Is Rewiring Targeted Protein Degradation for the Clinic
Targeted protein degradation has moved from elegant academic concept to one of the most closely watched frontiers in oncology, promising to drug the 80% of disease‑driving proteins that traditional inhibitors and even ADCs still struggle to rea...
25. Europe Doesn’t Need Boston Anymore: Inside Gilead’s $5B Tubulis Bet
For years, the narrative was simple: if you wanted a multibillion-dollar biotech outcome, you built in Boston or the Bay Area. Gilead’s up to $5 billion acquisition of Munich-based Tubulis just blew that up. In this episode, Mike Wa...
24. AL-S Pharma prepping a phase 3 trial of AP-101 in ALS
Progress in developing safe and effective therapies for amyotrophic lateral sclerosis (ALS) has been painfully slow. It is caused by the death of motor neurons in the central nervous system and the spinal cord, which leads to a loss of control ...
